Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target ...

An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Microsoft has launched the Azure AI Foundry Labs, a hub for developers, startups and enterprises to explore innovative from ...

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round.

AI helps scientists decode a cone snail toxin’s targets, paving the way for safer drug development and ecological research.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...